Clinical and Translational Radiation Oncology (Nov 2020)
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
- A. Hunt,
- I. Hanson,
- A. Dunlop,
- H. Barnes,
- L. Bower,
- J. Chick,
- C. Cruickshank,
- E. Hall,
- T. Herbert,
- R. Lawes,
- D. McQuaid,
- H. McNair,
- A. Mitchell,
- J. Mohajer,
- T. Morgan,
- U. Oelfke,
- G. Smith,
- S. Nill,
- R. Huddart,
- S. Hafeez
Affiliations
- A. Hunt
- The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK
- I. Hanson
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- A. Dunlop
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- H. Barnes
- The Royal Marsden NHS Foundation Trust, London, UK
- L. Bower
- The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK
- J. Chick
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- C. Cruickshank
- Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK
- E. Hall
- Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK
- T. Herbert
- The Royal Marsden NHS Foundation Trust, London, UK
- R. Lawes
- The Royal Marsden NHS Foundation Trust, London, UK
- D. McQuaid
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- H. McNair
- The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK
- A. Mitchell
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- J. Mohajer
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- T. Morgan
- The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK
- U. Oelfke
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- G. Smith
- The Royal Marsden NHS Foundation Trust, London, UK
- S. Nill
- The Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK
- R. Huddart
- The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK
- S. Hafeez
- The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK; Corresponding author at: The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK.
- Journal volume & issue
-
Vol. 25
pp. 46 – 51
Abstract
Whole bladder magnetic resonance image-guided radiotherapy using the 1.5 Telsa MR-linac is feasible. Full online adaptive planning workflow based on the anatomy seen at each fraction was performed. This was delivered within 45 min. Intra-fraction bladder filling did not compromise target coverage. Patients reported acceptable tolerance of treatment.
